Myeloid-derived suppressor cells and radiotherapy

C Jiménez-Cortegana, C Galassi, V Klapp… - Cancer Immunology …, 2022 - AACR
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of pathologically
activated, mostly immature, myeloid cells that exert robust immunosuppressive functions …

Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment

Y Deng, M Shi, L Yi, MN Khan, Z **a, X Li - Heliyon, 2024 - cell.com
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by producing
remarkable clinical outcomes for patients with various cancer types. However, only a subset …

[HTML][HTML] Metabolic reprogramming of immune cells in pancreatic cancer progression

H **ang, R Yang, J Tu, Y **, S Yang, L Lv, X Zhai… - Biomedicine & …, 2023 - Elsevier
Abnormal intracellular metabolism not only provides nutrition for tumor occurrence and
development, but also sensitizes the function of various immune cells in the immune …

Follicular helper T cells remodel the immune microenvironment of pancreatic cancer via secreting CXCL13 and IL-21

X Lin, L Ye, X Wang, Z Liao, J Dong, Y Yang, R Zhang… - Cancers, 2021 - mdpi.com
Simple Summary The immunosuppressive microenvironment is closely related to the poor
prognosis of patients with PDAC. Tfh cells play an anti-tumor function in various malignant …

Neutrophil in the pancreatic tumor microenvironment

L **, HS Kim, J Shi - Biomolecules, 2021 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy with a poor prognosis and low
survival rates. PDAC is characterized by a fibroinflammatory tumor microenvironment …

Regulation of T cells in cancer by nitric oxide

I Navasardyan, B Bonavida - Cells, 2021 - mdpi.com
The T cell-mediated immune response is primarily involved in the fight against infectious
diseases and cancer and its underlying mechanisms are complex. The anti-tumor T cell …

Two-in-one polymeric NO-donor prodrugs mediate precision and synergistic prostate cancer treatment

B Zhao, Y Wan, X Zhou, J Zhang, J Chen… - … Applied Materials & …, 2023 - ACS Publications
Chemotherapy predominates in clinical treatment of prostate cancer (PCa), while
irreversible resistance to chemotherapeutics and severe side effects hinder the therapeutic …

Targeting myeloid-derived suppressor cells to enhance the antitumor efficacy of immune checkpoint blockade therapy

X Li, J Zhong, X Deng, X Guo, Y Lu, J Lin… - Frontiers in …, 2021 - frontiersin.org
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature
myeloid cells that are activated under pathological conditions, such as cancer, or mature …

Metabolic and epigenetic orchestration of (CAR) T cell fate and function

B Akbari, Z Hosseini, P Shahabinejad, S Ghassemi… - Cancer Letters, 2022 - Elsevier
Longevity, functionality, and metabolic fitness are key determinants of chimeric antigen
receptor (CAR) T cell efficacy. Activated T cells follow an ordered differentiation program …

[HTML][HTML] MDSCs-derived GPR84 induces CD8+ T-cell senescence via p53 activation to suppress the antitumor response

J Liu, J Liu, G Qin, J Li, Z Fu, J Li, M Li… - … for Immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Methods The role and underlying mechanism that MDSCs or exosomes (Exo) regulates the
function of CD8+ T cells were investigated using immunofluorescence, fluorescence …